Skip to content

PET/CT to Identify Vulnerable Arterial Plaque

PET/CT to Identify Vulnerable Arterial Plaque

Status
UNKNOWN
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT00416065
Enrollment
800
Registered
2006-12-27
Start date
2004-04-30
Completion date
Unknown
Last updated
2006-12-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Cancer

Brief summary

The purpose of this research is to evaluate the presence, location and intensity of FDG uptake in the large arteries using the new technology of fused PET/CT imaging and to compare FDG uptake with the presence of arterial calcifications as seen on the simultaneously acquired CT, in order to determine if FDG was increases incalcified plaque or in a different location in the arterial wall. we will also evaluate the relationship between FDG localization and future cardiovascular events in out patient population

Interventions

DEVICEPET/CT imaging

Sponsors

Rambam Health Care Campus
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
SINGLE_GROUP
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
50 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Patients referred for clinical FDG-PET/CT studies * Patients 50 yr or older * Patients signed informed consent

Exclusion criteria

* Patients unable or unwilling to tolerate the scan until its completion

Design outcomes

Primary

MeasureTime frame
the impact of the imaging modality on patient management

Secondary

MeasureTime frame
the impact of the imaging modality on patient management

Countries

Israel

Contacts

Primary ContactOra Israel, MD
o_israel@rambam.health.gov.il972-4-8543009

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026